Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).
Synonyms: HIV Antibody Positivities, Seroconversions, AIDS, Positivities, Anti-HIV, Seropositivities, HIV, Antibody Positivities, HIV, HTLV-III Seropositivity, HIV Antibody Positivity, HIV Seropositivities, AIDS Seroconversion, HIV Seroconversions, Anti HIV Positivity, HTLV-III Seropositivities, Seropositivity, HTLV-III, AIDS Seropositivity, HTLV-III Seroconversions, HIV Seroconversion, Seropositivities, AIDS, Positivity, HIV Antibody, Seroconversion, AIDS, Positivities, HIV Antibody, Seroconversions, HIV, HIV Seropositivity, Positivity, Anti-HIV, Seroconversions, HTLV-III, Antibody Positivity, HIV, Seroconversion, HIV, Anti-HIV Positivity, AIDS Seropositivities, Seropositivity, HIV, Seroconversion, HTLV-III, HTLV-III Seroconversion, Seropositivities, HTLV-III, Seropositivity, AIDS, HTLV III Seroconversion, AIDS Seroconversions, HTLV III Seropositivity, Anti-HIV Positivities
Instance information
88; ANTI-HIV POSITIVITY was ANTI-HIV POSITIVE 1988-93; HIV ANTIBODY POSITIVITY was HIV ANTIBODY POSITIVE 1988-93 ,note category; HIV SERONEGATIVITY (Cat G) is also available; /diag /immunol permitted but use caution; coord IM with HIV-1 /immunol (IM) or HIV-2 /immunol (IM); do not confuse with HIV SEROPREVALENCE, an epidemiol concept; DF: HIV SEROPOS
D006679